TruthArchive.ai - Related Video Feed

Video Saved From X

reSee.it Video Transcript AI Summary
Over 100 members of Congress support a bill to fund Ozempic with Medicare at $1,500 a month, and most have taken money from Novo Nordisk, the drug's manufacturer. There is a push to recommend Ozempic for Americans as young as six for obesity, a condition claimed to be preventable. It is claimed that if 74% of Americans took Ozempic, the cost would be $3 trillion a year. Ozempic has made Novo Nordisk the biggest company in Europe, yet the Danish government recommends diet and exercise instead. It is claimed that for half the price of Ozempic, every American could receive regeneratively raised organic food and gym memberships. It is claimed that members of Congress are doing the bidding of Novo Nordisk instead of standing up for American farmers and children because Novo Nordisk is one of the largest funders of medical research.

Video Saved From X

reSee.it Video Transcript AI Summary
The speaker claims the tobacco industry applied their expertise in addiction to food production, creating ultra-processed foods that lack satiability, leading to overconsumption. They state that almost 1,000 chemicals in American foods are banned in Europe and elsewhere, and that these novel chemicals are poorly processed by the body. The speaker notes a significant increase in chronic disease since their uncle's presidency, when 6% of Americans had chronic diseases and there was no budget for it. Now, chronic disease costs $4.3 trillion, five times the military budget. Pharmaceutical companies, insurance companies, and hospitals profit from this. The speaker asserts that the medical advice we receive is compromised due to corporate capture.

Video Saved From X

reSee.it Video Transcript AI Summary
Over 100 members of Congress are backing a bill to fund Ozempic through Medicare at $1,500 monthly, many having received funds from Novo Nordisk, its European manufacturer. Once Medicare approves it, Medicaid follows. There's a push to prescribe Ozempic to kids as young as six for obesity, a largely preventable condition. With 74% of Americans obese, covering everyone's Ozempic would cost $3 trillion annually. Ozempic has made Novo Nordisk Europe's largest company, yet Denmark recommends diet and exercise instead. The company's value relies heavily on projected Ozempic sales in the US. For half the cost, we could provide organic food and gym memberships for every obese American. Why are politicians siding with a Danish company over American farmers and kids? Because Novo Nordisk heavily funds medical research, influencing media, politicians, and medical schools.

Video Saved From X

reSee.it Video Transcript AI Summary
Over 100 members of Congress support a bill to fund Ozempic through Medicare at $1,500 a month, despite many having received funding from its manufacturer, Novo Nordisk. This drug, aimed at treating obesity—a largely preventable condition—could cost the U.S. $3 trillion annually if prescribed widely, as 74% of Americans are obese. While Novo Nordisk thrives, the Danish government promotes diet and exercise instead. For half the cost of Ozempic, we could provide organic food and gym memberships for every obese American. The influence of Novo Nordisk extends to medical research funding, leading to complicity from media, politicians, and medical schools.

Video Saved From X

reSee.it Video Transcript AI Summary
Speaker 0 argues that history will view this presidency as probably the most reckless and corrupt in the history of the United States, and expresses fear that without change the country and the world risk major harm, including the possibility of World War III. They say, regardless of views on global leadership, that being on top “what good is it … if you've created an absolute hellscape?” They emphasize the need for the course to change and suggest the future of the United States as a cohesive country and the world is currently in question because of the administration’s behavior. Speaker 1 agrees that America used to hold the moral high ground—defending human rights, free speech, and free trade—but asserts that none of those things are true any longer. They claim America is “the terror regime of the world,” describing it as pillaging, stealing, bombing, assassinating, running color revolutions, lying, and doing everything possible to destroy others to keep America as the last nation standing on its pile of soon to be worthless debt. They state this is not a moral position from which to lead any civilization. Speaker 0 contends that America has the tools to be all those values, citing a great constitutional republican system, the federation of states, resources, and human capital. They note a problem, however: a “giant pile of worthless fiat paper,” with the bill coming due and the tantrums of an empire, referencing warnings by people like Gerald Celente and Alex Jones about a fiat bubble rupture. They say the question is where the country wants to be in the world, criticizing a lack of imagination among the “great and the good in America” about a compelling future. Speaker 1 adds a new issue: 31 million Americans are injecting themselves with GLP-1 drugs, which they say cause a 100% increase in risk of psychiatric disorders and suicidal ideation, especially among women, with the most use among 50–65-year-olds. They claim Trump is working to make these drugs more affordable so that more people can take them, potentially leading to half of US adults using a drug based on venom peptides of the Gila monster, a paralyzing agent, risking madness. They compare this to lead poisoning and reference Ozempic as one of these drugs. Speaker 0 asks, “What’s it called? Ozempic? Is that a GOP one?” Speaker 1 confirms “Ozempic,” and notes that the drugs are used for vanity to look healthy, not because people are actually healthy. They reiterate the core issue: what goes into bodies and the environment in which people live, stressing that there is an opportunity today to correct and improve the situation, and that many are taking that opportunity.

Video Saved From X

reSee.it Video Transcript AI Summary
Ozempic breaks people's bones. Pharmaceutical companies selling weight loss pills have side effects that include breaking people's bones. Instead of cleaning up their diet, eating organic, working out, getting rid of Wi Fi, and spending time in nature, people are going to pharmaceutical companies expecting results. When your bones break in half, it doesn't matter if you lose weight. Taking care of yourself and being healthy takes work. If you're concerned about weight loss, you should be concerned about what's in your house, what you're eating, the chemicals you're spraying all over your body, and the lotions you're putting all over your head. If you can't lose weight, it's probably your diet, and an all-organic diet can heal everything. Pharmaceutical companies poison people to gain weight, then sell them something to make them lose weight, which causes their bones to break, creating patients for life.

Video Saved From X

reSee.it Video Transcript AI Summary
Ozempic carries a black box warning for increasing the risk of all forms of medullary thyroid cancer within twelve months of use. Oncologists are seeing new cancer patients on Ozempic and Wegovy developing breast cancer in under a year. Thousands of Americans are reporting eye-rotting diseases from using Ozempic and Wegovy. Ozempic and Wegovy are made from protein from the Gila monster lizard. According to the Smithsonian Institute, Gila monster venom is more deadly and toxic than a western diamondback rattlesnake. The speaker asks if people taking Ozempic and Wegovy believe they are overweight, diabetic, or have heart disease due to a Gila monster venom deficiency.

Video Saved From X

reSee.it Video Transcript AI Summary
American medical groups, including the American Diabetes Association, accept money from processed food companies like Coke. Hospitals have soda machines and sponsorships from these companies. The ADA recommends small cans of Coke for diabetics despite rising diabetes rates. The medical system profits from sickness, not health.

Video Saved From X

reSee.it Video Transcript AI Summary
Novo Nordisk, the pharmaceutical company behind the weight loss drug Ozempic, is debunking conspiracy theories about profiting off people's health issues. They are lobbying the government to support the Treat and Reduce Obesity Act of 2023, which allows coverage for obesity treatment under Medicare. The company's stock has seen significant growth, and they have spent millions on lobbying and stock buybacks. While some board members have connections to other companies, Novo Nordisk aims to improve people's health. Critics argue that the drug has side effects and is expensive, but an article by Yoni Friedhoff, who received grants from Novo Nordisk, refutes these claims. Trusting the science and pharmaceutical companies is important for better health.

Video Saved From X

reSee.it Video Transcript AI Summary
Over 100 members of Congress support a bill to fund Ozempic through Medicare at $1,500 a month, despite many having received funding from its manufacturer, Novo Nordisk. Once approved for Medicare, the drug will likely extend to Medicaid, with recommendations for use in children as young as 6 for obesity, a largely preventable condition. With 74% of Americans classified as obese, the potential annual cost for Ozempic prescriptions could reach $3 trillion. While Novo Nordisk thrives on these projections, the Danish government advocates for dietary changes and exercise instead. For the cost of Ozempic, we could provide organic food and gym memberships for every obese American. The influence of Novo Nordisk in medical research funding raises concerns about Congress prioritizing corporate interests over American health and agriculture.

Video Saved From X

reSee.it Video Transcript AI Summary
Over 100 members of Congress support a bill to fund Ozempic with Medicare at $1500 a month, and most have taken money from Novo Nordisk, the drug's manufacturer. Once approved for Medicare, it goes to Medicaid, and there's a push to recommend Ozempic for Americans as young as 6 for obesity, a condition claimed to be preventable and recently rare. With 74% of Americans obese, the cost of Ozempic prescriptions for all of them would be $3 trillion a year. Novo Nordisk's value is based on projected Ozempic sales to Americans, yet the Danish government recommends diet and exercise instead. For half the price of Ozempic, every American could receive regeneratively raised organic food and gym memberships. Congress is allegedly doing the bidding of Novo Nordisk instead of supporting American farmers and children because Novo Nordisk heavily funds medical research, the media, politicians, and medical schools.

Video Saved From X

reSee.it Video Transcript AI Summary
Over a hundred members of Congress are backing a bill to fund Ozempic through Medicare at $1,500 monthly, many having received funds from Novo Nordisk, its manufacturer. Once Medicare approves, Medicaid follows. There's a push to prescribe Ozempic for obesity in Americans as young as six, a condition largely preventable. With 74% of Americans obese, covering Ozempic prescriptions would cost $3 trillion annually. Novo Nordisk's value relies heavily on projected Ozempic sales in the US, yet Denmark, their home country, favors diet and exercise over the drug. For half the cost of Ozempic, we could provide regeneratively raised organic food to every American, three times a day, and gym memberships for every obese American. Why is Congress prioritizing this company over American well-being? I've dedicated my life to solving the childhood chronic disease crisis, and I see an opportunity for bipartisan change to improve American health, our economy, and our nation's spirit.

Video Saved From X

reSee.it Video Transcript AI Summary
Ozempic has rapidly become a cultural phenomenon, with one in eight US adults having tried GLP-1 drugs. The company producing Ozempic is now valued higher than Coca-Cola and McDonald's combined. Online discussions mention side effects like Ozempic face, hair loss, and severe stomach problems, alongside reports suggesting potential benefits for fertility, Alzheimer's, and even shopping addiction. The speaker questions the complete truth about GLP-1 drugs and weight loss, and has spent months researching and attempting to obtain GLP-1 medication.

Video Saved From X

reSee.it Video Transcript AI Summary
The speaker argues that modern medicine creates enormous financial incentives around chronic diseases. Diabetes is described as a $110 billion per year industry, leading to the suggestion that there might be meetings in big pharma to undermine efforts to end the disease. If asked to design a diet that guarantees diabetes, the speaker would download and pass along the American Diabetes Association’s dietary guidelines, claiming that the guidelines themselves promote an insulin-dependent diet. The breakfast example given is a glass of orange juice, a bowl of oatmeal with crushed brown sugar and natural honey, and a snack of yogurt with fruit on the bottom, totaling 44 grams of sugar. The discussion shifts to pharmaceutical acquisitions, noting that Pfizer paid $6.6 billion for Arena Pharmaceuticals and asserting that Arena “fixes myocarditis, pericarditis, and diffuse vasculitis as a consequence of vaccine injury,” labeling this as a factual claim about Arena’s products. The speaker links folic acid production to Monsanto with other medications, asserting that folic acid is the leading cause of ADD, ADHD, and manic depression and that these conditions are treated with Ritalin, Vyvanse, and Adderall, dismissing it as a coincidence rather than a conspiracy. Vitamin D deficiency is highlighted as a major health issue, with the speaker claiming that 50% of the audience is clinically deficient in vitamin D3, and that 85% of African American and Latino populations are deficient due to skin pigment. This deficiency, they argue, correlates with higher all-cause mortality and weaker immune systems, and is used to explain why COVID affected minorities disproportionately—not due to minority status but pigment. The pandemic period is criticized for weakening immune systems through social distancing, residential quarantining, and masking. The speaker contends that humans are meant to interact, and such interaction builds a strong immune system. A personal maxim is shared: aging is the aggressive pursuit of comfort; the more comfort sought, the faster aging occurs. The speaker urges resisting discomfort—exercising, taking cold showers or plunges, dieting, and tolerating some hunger—arguing that avoiding discomfort leads to negative health outcomes. Finally, they caution against restricting activities for older people based on weather, asserting that people should go outside regardless of heat or cold and embrace discomfort rather than avoiding it.

Video Saved From X

reSee.it Video Transcript AI Summary
Politicians have long promised to address the discrepancy between drug prices in the U.S. and Europe. This issue was central to Bernie Sanders' presidential campaigns. However, these promises were never fulfilled because Congress is heavily influenced by the pharmaceutical industry. There is at least one pharmaceutical lobbyist for every member of Congress, the Senate, and the Supreme Court.

Video Saved From X

reSee.it Video Transcript AI Summary
Ozempic causes appetite suppression, leading to weight loss, but also nausea and vomiting, causing some to stop usage. While effective and offering metabolic benefits from weight loss, it's very expensive, costing $1,300-$1,700 monthly. Weight returns upon cessation without lifestyle changes; it doesn't address behavior or habits. A significant downside is muscle loss, with 50% of weight lost being muscle, which is crucial for metabolism and overall health. Counteracting this requires increased protein intake and weight training. Metabolism may be slower post-treatment due to muscle loss. Long-term side effects are emerging, including a 450% increase in bowel obstruction and a 900% increase in pancreatitis. The drug addresses a symptom, not the cause, which is a toxic environment, lifestyle, and food system. Addressing obesity requires policy changes, agricultural and food system reform, and widespread education, which faces resistance from the large food industry.

Video Saved From X

reSee.it Video Transcript AI Summary
Ozempic carries a black box warning that it increases the risk of all forms of medullary thyroid cancer within twelve months of use. Oncologists are seeing new cancer patients on Ozempic and Wegovy developing breast cancer in under a year. People magazine reported thousands of Americans are experiencing eye-rotting diseases while using Ozempic and Wegovy. Ozempic and Wegovy are made from protein from the Gila monster lizard. The Smithsonian Institute told CNN that Gila monster venom is more deadly and toxic than a western diamondback rattlesnake. The speaker asks if people taking Ozempic and Wegovy believe they are overweight, diabetic, or have heart disease because they are Gila monster venom deficient.

Video Saved From X

reSee.it Video Transcript AI Summary
Big food, big pharma, big chemicals get super wealthy. Right? What is the product of health care? It's a healthy body. If we take The US population and compare it to the world, we're at the very bottom when it comes to health, yet we spend the most for health care. Over $4,100,000,000,000 every single year.

Video Saved From X

reSee.it Video Transcript AI Summary
The average 65-year-old in the US takes about seven drugs. 95% of people on the USDA nutrition guidelines had conflicts of interest with food companies, influencing school lunches, where the USDA serves 3 billion meals yearly. Kraft Heinz is brokering deals to put Lunchables in schools, a top growth area. Novo Nordisk, the Ozempic manufacturer, is now Europe's most valuable company, with almost all revenue from the US due to a broken system. 30% of Americans with insurance coverage stop using Ozempic within three months, despite it being touted as a lifetime drug. Lawsuits are emerging regarding gastrointestinal issues and stomach paralysis, which may persist after discontinuing the drug. The EU is probing suicidal ideation linked to Ozempic. The American Academy of Pediatrics recommends Ozempic as a first-line defense for teens based on a 68-week study. Pharma is the largest TV news ad spender, and Novo Nordisk is a major funder of obesity research, medical groups, and civil rights groups, including paying the NAACP, who claims that not supporting Ozempic is racist. Analyst reports assume increased obesity rates, and loans for obesity treatment centers project growth in obesity. Weight Watchers, now an Ozempic prescriber, shifted from personal accountability due to Ozempic's superior business model.

Video Saved From X

reSee.it Video Transcript AI Summary
Ozempic, a diabetes drug that aids weight loss, is gaining popularity despite concerns. Cali Means highlights three major issues: first, obesity is a symptom of deeper metabolic dysfunction, not a deficiency treatable by medication. Second, the drug has significant side effects, including gastrointestinal issues and potential mental health risks, with many users discontinuing it within months. Third, systemic corruption in healthcare, where pharmaceutical companies influence medical guidelines and funding, exacerbates the problem. Instead of addressing root causes like diet and lifestyle, the focus remains on lifelong drug dependency. Means advocates for a shift towards preventive measures, emphasizing better nutrition and exercise as essential for improving public health. He believes that reforming healthcare practices and policies can reverse the current metabolic health crisis.

Video Saved From X

reSee.it Video Transcript AI Summary
The U.S. faces a severe chronic disease crisis, costing $4.3 trillion annually, which is five times the military budget. Medical expenses for chronic diseases have skyrocketed from zero during previous administrations to 95% of healthcare spending today. This situation is exacerbated by processed foods, chemicals, and a profit-driven healthcare system that benefits from keeping people sick. Pharmaceutical companies profit from lifelong patients, with drugs like Ozempic costing $1,500 weekly. A proposed bill could lead to $3 trillion in costs for treating obesity. Instead, for a fraction of that amount, providing every American with three organic meals daily could eliminate diabetes, a condition treatable with proper nutrition and exercise.

My First Million

The Dark Story Behind Ozempic’s $500B Business Empire
reSee.it Podcast Summary
The discussion centers around the issue of obesity and the use of OIC (Obesity Intervention Drugs) in America, which the hosts argue is symptomatic of a larger problem in the healthcare system. Telly describes OIC as "liquefied anorexia," suggesting that it merely masks the root causes of obesity rather than addressing them. He criticizes the medical education system for neglecting nutrition training, citing an anecdote about a Stanford surgeon dismissing dietary interventions. Kelly highlights the alarming statistics of obesity in America, noting that 50% of teens are overweight or obese, compared to just 3% in Japan. He argues that the healthcare industry profits from managing chronic diseases rather than preventing them, with a focus on drugging patients instead of addressing lifestyle factors. The conversation touches on the influence of pharmaceutical companies on medical education and policy, revealing that many medical schools are funded by these companies, which affects the integrity of healthcare recommendations. The hosts discuss the economic implications of the obesity crisis, predicting that healthcare costs could consume 40% of GDP in the next 20 years. They emphasize the need for systemic change, advocating for a shift towards healthier food systems and incentivizing better lifestyle choices rather than relying on drugs like Ozempic. They also explore the historical context of the pharmaceutical industry, linking it to the rise of chronic conditions and the segmentation of medical specialties that prioritize profit over holistic health. The conversation concludes with a call to action for entrepreneurs and investors to focus on sustainable health solutions, emphasizing that the current trajectory is unsustainable and detrimental to American society. The hosts express a desire for a healthier future, advocating for a reevaluation of dietary practices and healthcare policies.

The Megyn Kelly Show

Fighting the Establishment in DC, and Why Woke Lost - Piers Morgan, Eric Trump, and Calley Means
Guests: Piers Morgan, Eric Trump, Calley Means
reSee.it Podcast Summary
Megyn Kelly hosts a wide‑ranging discussion with Piers Morgan, Eric Trump, and Calley Means that blends media critique, political strategy, and public‑health reform with personal anecdotes from the Trump orbit. The episode pivots around a centralized theme: the perceived rise of woke culture and its impact on broadcasting, journalism, and policymaking, including a highlight on Condé Nast and Teen Vogue as symbols of what the guests see as a woke establishment. Megyn frames the conversation with pride in a no‑nonsense, anti‑establishment stance and tees up a rundown of guests who embody different facets of the movement: Piers Morgan’s critique of woke culture and his new book, Woke Is Dead; Eric Trump’s reflections on presidential politics, media bias, and his family’s legal and political battles; and Calley Means’s health‑policy project, Maha, which advocates for systemic healthcare reform and healthier food policies. The dialogue weaves through contemporary hot topics—media double standards, the weaponization of government, and the push to “make America healthy again.” The interview with Calley Means spotlights a policy‑oriented critique of America’s health landscape: rampant obesity, the influence of ultra‑processed foods, and the role of government subsidies. Means describes a reform agenda that seeks to realign incentives toward wellness, reduce dependence on high‑priced drugs like Ozempic, and empower families with practical nutrition and access to better health outcomes. The guests also reflect on immigration, the labor market, and the need to prioritize American workers, with Megyn pressing for deportations of those here illegally unless lawful status is established, while also signaling a broader critique of the political class and the media ecosystem that amplifies partisan narratives. The episode closes with a candid exchange about 2028 political possibilities, the resilience of the MAGA movement, and Eric Trump’s personal assessment of leadership, media, and the path forward for a Republican administration. The conversation is anchored by personal anecdotes—from backstage dynamics to family stories, including exchanges about Barron Trump and the Trump Library—providing a candid portrait of a family and a political movement navigating today’s polarized climate.

Tucker Carlson

Ep. 72 Big Pharma Is Fooling You Again, and You Don't Even Know It
Guests: Calley Means
reSee.it Podcast Summary
Tucker Carlson discusses skepticism towards new pharmaceutical products, particularly Ozempic, a diabetes drug that aids weight loss. Cali Means, founder of TruMed, argues that Ozempic is problematic for three main reasons. First, obesity is a symptom of deeper metabolic dysfunction, not a deficiency that can be solved with medication. He highlights the alarming rates of obesity and prediabetes in America, attributing these issues to corrupt food industry practices and government subsidies favoring processed foods. Second, he claims that Ozempic has severe side effects, including gastrointestinal issues and potential mental health risks, with many patients discontinuing use due to these problems. Third, Means points to systemic corruption within healthcare, where pharmaceutical companies influence medical guidelines and research funding, leading to a focus on lifelong drug dependency rather than addressing root causes of health issues. He emphasizes the need for a shift towards better nutrition and exercise, criticizing the current healthcare model that profits from chronic illness. Means concludes by advocating for a reevaluation of public health policies to prioritize metabolic health.

Mind Pump Show

Mind Pump Challenges Big Pharma: A Look at The Future of Health in America
reSee.it Podcast Summary
The pharmaceutical industry benefits from a population that is overweight and unhealthy, as they represent a significant consumer base. Dr. Fatima Stanford, a member of the Biden USDA's dietary guidelines advisory committee, claims that genetics is the primary cause of obesity, with a 50 to 80 percent risk of obesity for children of obese parents. She also describes obesity as a brain disease, suggesting that the brain regulates eating and storage. However, the hosts argue that lifestyle factors play a crucial role in obesity and express concern over the narrative that genetics absolves personal responsibility. They highlight the pharmaceutical industry's profit motives, noting that a larger market of obese individuals leads to increased drug sales. The discussion points to the alarming trend of labeling obesity as a disease, which could open the door for more medications and shift focus away from lifestyle changes. The hosts emphasize the importance of empowerment and personal agency in addressing obesity, warning against the potential consequences of accepting a narrative that diminishes individual responsibility.
View Full Interactive Feed